Authors say tool can be incorporated for routine screening in primary care settings
FRIDAY, Oct. 14, 2022 (HealthDay News) — The CHILDhood Asthma Risk Tool (CHART) can identify children at high risk for asthma at as early as 3 years of age, according to a study published online Oct. 6 in JAMA Network Open.
Myrtha E. Reyna, from the Hospital for Sick Children in Toronto, and colleagues developed and evaluated the use of a symptom-based screening tool to detect children at high risk for asthma at age 3 years, persistent wheeze symptoms at 5 years, and health care burden.
The researchers found that CHART applied in the CHILD Study at 3 years of age outperformed physician assessments and the modified Asthma Predictive Index in predicting persistent wheeze (area under the receiver operating characteristic curve [AUROC], 0.94), asthma diagnosis (AUROC, 0.73), and health care use (emergency department visits or hospitalization for wheeze or asthma; AUROC, 0.70). In two external validation sets, CHART had a similar predictive performance for persistent wheeze in children at 5 years of age (AUROC, 0.82) and at 7 years of age (AUROC, 0.87).
“These findings suggest that CHART may be incorporated as a routine screening tool in primary care settings to trigger timely treatment initiatives and promote active disease monitoring,” the authors write.
Guidelines Updated for Prostate Cancer Screening
EHR-Enabled QI Intervention Improves Chlamydia, Gonorrhea Screening in Teens
Genetic Screening Can ID Hemoglobinopathy Prevalence
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Guidelines Updated for Short-Course Radiation for Localized Prostate Cancer
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
ASTRO Issues Guidance for Use of Radiation Therapy in Bladder Cancer
Higher Intake of Saturated, Animal Fats May Increase Mortality in Prostate Cancer